Iva N.
About Iva N.
Iva N. is a Chief Biophysicist with extensive experience in biophysics and biochemistry, currently working at Exscientia and The University of Dundee. She specializes in fragment screening using Surface Plasmon Resonance technology and has developed novel biosensor technologies for analyzing biomolecular interactions.
Work at Exscientia
Iva N. has served as Chief Biophysicist at Exscientia since 2018. In this role, she focuses on advancing drug discovery through innovative biophysical techniques. Her expertise in fragment screening and Surface Plasmon Resonance (SPR) technology contributes to the development of novel therapeutic candidates. Exscientia is known for its AI-driven approach to drug design, and Iva's work supports the integration of biophysical methods into this framework.
Education and Expertise
Iva N. earned her PhD in Biochemistry from Masaryk University Brno, where she studied from 1995 to 2003. Her academic background provides a strong foundation for her research in biophysics and biochemistry. Iva specializes in fragment screening and has developed novel biosensor technologies for analyzing biomolecular interactions. She has significant expertise in membrane protein screening, particularly with GPCRs and ion channels.
Background
Iva N. has a diverse background in scientific research, having worked in various prestigious institutions. She was a Postdoctoral Scientist at the University of Utah from 2003 to 2006, followed by a position as Principal Scientist at Pfizer from 2006 to 2008. She then joined The University of Dundee as an Independent Investigator, where she worked from 2008 to 2016. In 2016, she transitioned to her current role at Exscientia.
Achievements
Throughout her career, Iva N. has made significant contributions to the field of biophysics. She has developed novel biosensor technologies that enhance the analysis of biomolecular interactions. Her work in fragment screening using SPR technology has been pivotal in advancing drug discovery processes. Iva's expertise in membrane protein screening has also positioned her as a key figure in the study of GPCRs and ion channels.